We are live on
!
Find out more
FA
Fagan Associates Portfolio holdings
AUM
$813M
1-Year Est. Return
37.92%
This Fund
S&P 500
This Quarter
Est. Return
-2.13%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+676.44%
AUM
$600M
AUM Growth
-$29.9M
(-4.8%)
Cap. Flow
-$8.71M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
38.25%
Holding
136
New
5
Increased
43
Reduced
63
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$4.28M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.7M |
| 3 |
JPMorgan Core Plus Bond ETF
JCPB
|
+$2.29M |
| 4 |
Robinhood
HOOD
|
+$2.2M |
| 5 |
IBM
IBM
|
+$1.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$4.87M |
| 2 |
Pfizer
PFE
|
+$3.71M |
| 3 |
Dell
DELL
|
+$3.35M |
| 4 |
Adobe
ADBE
|
+$3.2M |
| 5 |
Tesla
TSLA
|
+$2.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.91% |
| 2 | Financials | 11.31% |
| 3 | Communication Services | 8.64% |
| 4 | Consumer Discretionary | 7.39% |
| 5 | Healthcare | 6.37% |
Similar funds
KCP
ACM
BCM
RIM
CCM
VT
UM
IAM
Fagan Associates's Q1 2025 Portfolio in Review
As of Q1 2025, Fagan Associates held 136 positions worth $600M, down 4.8% from $629M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Fagan Associates's Q1 2025 filing shows 5 new, 43 increased, 63 reduced and 12 closed positions. Its largest new stake was Robinhood: 46,270 shares worth $1.93M. The largest sale was Palantir, an estimated $4.87M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Communication Services.
- Fagan Associates's largest Q1 2025 buy was Robinhood: 46,270 shares worth $1.93M.
- Fagan Associates added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, an estimated $4.28M increase.
- Fagan Associates's biggest Q1 2025 reduction was Palantir, cutting an estimated $4.87M.
- Fagan Associates fully exited Pfizer in Q1 2025, selling an estimated $3.71M.
- Fagan Associates's ten largest holdings make up 38% of its $600M portfolio in Q1 2025.
- Fagan Associates opened 5 new positions and closed 12 in Q1 2025.
- Fagan Associates's portfolio value fell 4.8% quarter-over-quarter to $600M.
Based on Fagan Associates's 13F filing for Q1 2025, filed 6 May 2025.